Lightspeed is in discussions to lead the funding round, sources say.

Lightspeed is in discussions to lead the funding round, sources say.

Miles Wang, an OpenAI researcher, is leaving to launch a $2B-valued startup focused on AI-driven drug discovery, with several colleagues expected to join the initiative.